With the well established vaccine industries in China, and large numbers of overseas Chinese biologists and entrepreneurs returned to China, and increasing economic growth of China in the past two decades, China like other Asia countries are attracting overseas pharmaceutical and biotech companies in Chinese vaccine R & D outsourcing market. The driving forces shaping the sector are not only the cost concerns but also the capacity and productivities. The huge pool of talented diligent and responsible Chinese professionals have support more big and small company vaccine pipeline development and release their timeline pressure. Both customers and suppliers are eager to take advantage the wave. So, you are welcomed to provide Segments, size, and growth of the vaccine market demand analysis to WCV 2008.
The Sessions of Vaccine R & D outsourcing invite you to tell your story in:
Vaccine R & D Services
• Bioprocess Services
• Epitope or Antigen Production
• Vaccine Process Research
• Biology Services
• Protein Expression
• Structural Analysis
• Immunological Studies
• Tox-Studies
• Assay Development
• PK/PD and Early ADMET
• Pharmacological and Efficacy Studies Services
• Vaccine Manufacturing
Other Services for Drug Discovery
Through the dynamic involvement from you, we hope you can share with our colleagues in:
1) Needs for Vaccine R & D and Why Outsourcing?
2) Cost and Safety Concerns in Vaccine R & D Outsourcing
3) Are VCs interested in Promote Outsourcing?
4) Trend of Globalization in Vaccine Development
5) Is a Vaccine at Reach?
6) What are the factors shaping the Vaccine discovery and production outsourcing market?
7) What are the major types of vaccine discovery services and which are growing fastest?
8) What are the implications of off shoring for this market?
9) What do customers look for in a supplier of generic vaccines?
10) What do vaccine suppliers do to make them successful?
11) Who are the leaders in vaccine R & D and Production market? Who are some promising newcomers?
12) How large is the Vaccine Outsourcing market and how fast is it growing?
13) Vaccine Outsourcing Decision Process
14) Academic vs. Commercial CRO for Vaccine Development
15) How to Select a Vaccine R & D CRO
16) Factors Driving the Vaccine CRO Selection Decision:
17) Negotiating the Deal in Vaccine Therapeutics Discovery and Development
18) What factors should a client consider when deciding whether to do a project in-house or outsource it in China or Asia?
19) Is it in his best interest to seek a domestic outsourcing partner, or go with a Chinese supplier?
20) How does he select the CRO that is best for him?
21) What are the best practices when working with a CRO?
22) How do you measure his effectiveness?
23) How do you avoid problems with your CRO?
24) How do you maximize benefits?
25) Advantages and Disadvantages have become your major concern for domestic suppliers and clients alike.
26) Provide your value opinion on the Pros & Cons on Drug Discovery Outsourcing in India, China, and Eastern Europe by comparing with some of their limitations.
27) Tell Big pharma strategies for offshoring Vaccine Development and Mannufacturing
28) Working with Your Vaccine R & D CRO
29) Elements of the Contracts in Vaccine Development
30) How to Help Your CRO and Head Off Problems
31) Effective Alliance Management
32) Measuring Effectiveness of a Deal in Vaccine Development
33) From biological building block to final vaccine Product Supply Contract
34) Fee-for-Service and Full-Time Equivalent (FTE)
35) Collaborative Research Agreement
36) Non-Exclusive Alliance
37) Exclusive Strategic Alliance
38) How to Doing Outsourcing Business in China?
39) What Are the Barriers to Integration?
40) What Are the Issues Regarding Language?
41) What Are the Relative Strengths of China in Outsourcing Comparing with other countries?
42) China's IP and Regulatory Environment
43) Clinical Trials in China
44) China¡¯s Advantages & Limitations
45) The Chinese Market
46) What Customers Seek in a CRO
47) Selection Criteria
48) Keys to Outsourcing Success
49) What the Pharma Industry Spends on R&D
50) What Pharma Spends on Outsourcing
51) Clinical & Pre-clinical Research
52) Pre-Pharma Model
53) Partnering Model
54) What business are we in and what business do we want to be in?
55) How does my unique technology become a market opportunity?
56) What services will we provide?
57) How will we attract and sell customers?
58) What should we do to make sure the assignment is successful?
If you are one of the key CRO players and want to share your successful stories or want to be part of it, please join us now!.
Contacts:
